pubrio
Sanyou Biopharmaceuticals logo

Sanyou Biopharmaceuticals

Privately Held
sanyoubio.com
生物技術研究200+ employeesFounded 2015🇺🇸 美國

Sanyou Biopharmaceuticals is a high-tech biopharmaceutical company driven by the mission of “To make it easy to develop new drugs worldwide”. The company is committed to fundamentally addressing the key challenges at the source of innovative drug development. Powered by its AI-STAL and supported by Sanyou Al-Drug Accelerator(SAI-DA), Sanyou provides comprehensive, one-stop solutions for innovative drug discovery, with a particular focus on molecular discovery and selection. Sanyou Bio has been dedicated to developing a world-class innovative biological drug R&D hub and to working collaboratively with partners worldwide to accelerate the development of innovative therapeutics. Headquartered in Shanghai, China, Sanyou has established global business centers across Asia, North America, and Europe, forming an international business network. The company currently operates and has planned over 20,000 square meters of R&D and GMP facilities. Sanyou has established strong collaborations with more than 2,000 pharmaceutical and biotech companies worldwide, empowering over 1,200 new drug discovery and development projects. It has completed more than 50 collaboration projects, over 10 of which have advanced to IND approval and clinical development stages. The company has filed over 170 invention patents, with more than 30 granted. It has also obtained over 10 national and international qualifications and system certifications, including National High-Tech Enterprise, Shanghai “Specialized and Innovative” Enterprise, ISO9001, and ISO27001.

成立年份
2015
員工
200+
行業
生物技術研究
公司類型
Privately Held
總部
🇺🇸Cambridge (+4)
專長
健康及福祉研究與發展生物技術研究生物產業

擴張情報

全新 · Pubrio 獨家

我們正在追蹤 Sanyou Biopharmaceuticals 的市場擴張

全球擴張

即時
階段
探索中投入中進入中營運中

活動脈搏

過去 90 日內有 3 個訊號。

過去 90 日
招聘
0
無活動
市場推廣與公關
0
無活動
產品與技術
3↑ +100%
產品發布
+2個類別已鎖定
已顯示 5 個中的 3 個
值得了解

關於 Sanyou Biopharmaceuticals 的常見問題

關於 Sanyou Biopharmaceuticals 業務、市場及增長訊號的快速解答。

Sanyou Biopharmaceuticals is a high-tech biopharmaceutical company driven by the mission of “To make it easy to develop new drugs worldwide”. The company is committed to fundamentally addressing the key challenges at the source of innovative drug development. Powered by its AI-STAL and supported by Sanyou Al-Drug Accelerator(SAI-DA), Sanyou provides comprehensive, one-stop solutions for innovative drug discovery, with a particular focus on molecular discovery and selection. Sanyou Bio has been dedicated to developing a world-class innovative biological drug R&D hub and to working collaboratively with partners worldwide to accelerate the development of innovative therapeutics. Headquartered in Shanghai, China, Sanyou has established global business centers across Asia, North America, and Europe, forming an international business network. The company currently operates and has planned over 20,000 square meters of R&D and GMP facilities. Sanyou has established strong collaborations with more than 2,000 pharmaceutical and biotech companies worldwide, empowering over 1,200 new drug discovery and development projects. It has completed more than 50 collaboration projects, over 10 of which have advanced to IND approval and clinical development stages. The company has filed over 170 invention patents, with more than 30 granted. It has also obtained over 10 national and international qualifications and system certifications, including National High-Tech Enterprise, Shanghai “Specialized and Innovative” Enterprise, ISO9001, and ISO27001.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。